Baseline | After 12 months | Difference | |||||||
---|---|---|---|---|---|---|---|---|---|
Group A FEV1 ≥ 80% | Group B FEV1 < 80 ≥ 60% | Group C FEV1 < 60% | Group A FEV1 ≥ 80% | Group B FEV1 < 80 ≥ 60% | Group C FEV1 < 60% | Group A FEV1 ≥ 80% | Group B FEV1 < 80 ≥ 60% | Group C FEV1 < 60% | |
TOTAL COSTS | 782.37 (±51.60) | 1,592.08 (±159.67) | 2,313.83 (±283.61) | 709.30 (±30.19) | 2,040.61 (±192.66) | 2,636.76 (±286.23) | −73.07 (±51.19) (p < 0.001) | 448.52 (±196.20) (p < 0.001) | 322.93 (±316.64) (p 0.012) |